The GUNA Method: Understanding Physiological Regulating Medicine

Part 1 of a two-part Deep GUNA Research series on the GUNA Method itself, for practitioners.

This article is written for a practitioner audience and draws directly on GUNA's own published theory material on Physiological Regulating Medicine (the GUNA Method). It is educational in nature and does not replace clinical judgement or personalised medical advice.

Everything else in our Deep GUNA Research series — the INET protocols, the Collagen Medical Devices, the individual cytokine and hormone remedies — sits on top of a single underlying clinical model. That model is Physiological Regulating Medicine, known as the GUNA Method. This article sets out what it is, the biological reasoning behind it, and the receptor-level mechanism GUNA proposes for why extremely low concentrations of hormones, cytokines and neuropeptides can have a therapeutic effect at all. The article that follows this one covers how GUNA translates the theory into a three-phase clinical model — PNEI Rebalance, Drainage, and Symptom Treatment — with the specific product ranges attached to each phase.

Definition

GUNA defines Physiological Regulating Medicine as "the most up-to-date integration of conventional medicine and homeopathic medicine." The Method draws on current knowledge in homeopathy, homotoxicology, Psycho-Neuro-Endocrino-Immunology (PNEI) and nutrition, combining the diagnostic and physiological framework of conventional medicine with the therapeutic approach of evidence-based homeopathy.

Its central therapeutic idea is a specific one: restoring physiology through communicating molecules — hormones, neuropeptides, interleukins, and growth factors — prepared in homeopathic dilutions, at the same physiological concentration as the biological milieu they act on. GUNA's own framing is that the homeopathic dilution-dynamization process makes these communicating molecules more effective, providing a biofeedback mechanism capable of restoring the body's homeostatic balance.

Three Foundations

GUNA presents Physiological Regulating Medicine as the natural development of Homotoxicology, just as Homotoxicology was itself the physiological development of classical Homeopathy. It rests on three foundations, each contributing a different layer to the clinical model:

1. Homeopathy and Homotoxicology. Homeopathy contributes a holistic view of the person and their disease process, and the principle of similarity (the study of pharmacological effects of homeopathized plant, mineral and animal substances on healthy subjects, applied inversely in illness) — used to correct the aspecific reactive structure conditioning why and how a person becomes unwell. Homotoxicology contributes functional and structural recovery (detoxification and drainage of connective tissue, emunctorial drainage, restoration of physiological cell metabolism) and neutralisation of etiological causes via the immunotherapeutic action of nosodes.

2. PNEI (Psycho-Neuro-Endocrino-Immunology). This is the layer specific to Physiological Regulating Medicine: regulation of neuroendocrine balance via homeopathized hormones and neuropeptides, and recovery of immune efficiency via homeopathized cytokines.

3. Dietary Supplementation. Plastic support for protein synthesis via the Master Amino Acid Pattern (MAP — GUNA's term for the ideal combination of amino acids for the human body), correct coenzyme activity via oligoelements and vitamins, and protection from free radicals via antioxidants.

The Body as a Steady-State System

GUNA's account of disease draws on Von Bertalanffy's systems theory, describing the body as a "steady-state flow system" — an open system that exogenous and endogenous stressors continually penetrate, altering homeostatic balance. Maintaining that balance is the job of the PNEI structure: the endocrine and immune systems interact continuously via neuropeptides, hormones and interleukins, and it's this interaction that produces ongoing adaptation.

When a stressor is introduced, the system responds along one of two paths: it either adapts and returns to homeostasis, or the alteration persists and the process becomes pathological — with hyper- or hypo-compensatory production of hormones, interleukins and neurotransmitters, and storage of the stressor itself within the matrix (matrix-cell intoxication), eventually leading to PNEI balance alteration and chronicity.

Where the Stressor Is Stored: The Matrix

GUNA's account of chronicity centres on a single anatomical structure: the loose pericellular fibrillar connective tissue, which it calls the matrix. The deposit of toxins at the interstitial space of this tissue is, GUNA argues, both an adaptive mechanism and the first sign of chronicity.

An intoxicated matrix stops carrying out its defensive, structural and filtering functions. It blocks the passage of oxygen and nutrients, forcing cells to adapt their metabolism (for example, a shift in fibroblast function from aerobic to anaerobic). It also blocks the passage of hormones, neuropeptides and interleukins, and the tissue's histological framework shifts progressively toward fibrosis and sclerosis.

At the same time, the organism mounts a complex adaptive response — inflammatory (via IL-1, TNF-α) or hormonal and neuropeptide-driven (via prolactin and cortisol, along the lines of Selye's stress response). The trouble starts when this response persists too long or runs in excess — due to a defence deficit, a PNEI imbalance, or suppressive pharmacological intervention. Target cells respond by closing their membrane receptors, a process GUNA calls "adaptation to the non-response," and this receptor down-regulation is, in GUNA's model, the mechanistic bridge between an acute adaptive response and true chronic disease.

The concept of "adaptation to the non-response": a ligand excess determines the down-regulation of membrane receptors. This is a mechanism for the maintenance of homeostasis — the cell, in order to maintain its functional balance, closes its receptors, but this leads first to a slowing and then to a loss of function.

Only by recovering the physiological function of the matrix — through drainage — and re-establishing correct membrane receptor function — through the concentrations of relation molecules the GUNA Method is built around — can cellular function, and organic homeostasis, be recovered.

The Vessel-Matrix-Membrane Receptor Unit

The loose pericellular connective tissue was, for a long time, understood only as structural support. GUNA's model reframes it as the body's System of Base Regulation — the interface between the "external world" (the vessel system) and the "internal world" (the cell). Changes to this matrix affect cellular dynamics directly: it stores and transmits information as instructions for the cell's physiological function, and it's where cytokines, neuropeptides and hormones coordinate the wider PNEI network.

GUNA frames this as a single morphofunctional unit — the vessel-matrix-membrane receptor continuum, running from the blood capillary through the lymphatic capillary, across the matrix, to the membrane receptor on the target cell. Physiological Regulating Medicine, GUNA states, "focuses on the role played by the matrix in physiopathological processes and makes it the privileged target of its therapy." This continuum, in GUNA's account, plays a vital role both in triggering and developing pathological processes and in the healing process itself.

The membrane receptor sits at the centre of this: what matters isn't only the quantity of ligand — hormone, cytokine or neurotransmitter — present, but the receptor's affinity for binding it. GUNA's own framing: only the physiologic concentration is able to activate or reactivate the membrane receptors, and consequently the correct function of the target cell. Accumulation of stressors — physical or mental — at this vessel-matrix-receptor unit is what triggers pathological onset and progression, via dysregulation of neuro-immune-endocrine homeostasis (either excessive or deficient production of neuropeptides, cytokines and hormones), which in turn alters the structure and function of the cell membrane itself.

The Low-Dose Mechanism

This is the theoretical core of the GUNA Method, and the part that explains why its products are dosed the way they are. GUNA's argument runs: complex systems like the vessel-matrix-membrane receptor unit can only be intervened on therapeutically using delicate elements — homeopathized cytokines, neuropeptides and hormones — at concentrations that match these substances' own physiological dilution range.

Low dose action mechanism: the action mechanism of homeopathic cytokines and homeopathic hormones consists of sensitization or activation of units of cellular or plasmatic receptors, by virtue of their high dilution — the same dilution these substances work at physiologically: 10⁻⁶ (microgram) or 10⁻⁹ (nanogram) for cytokines, and 10⁻¹² (picogram) for hormones. This receptor sensitization allows the trigger of chain reactions and a restart of the biological function of the whole neuro-immune-endocrine network. Homeopathic cytokines and hormones work by bringing to the system an information able to activate autoregulation mechanisms.

The concentration range GUNA works in — 10⁻⁶ to 10⁻¹² — is not an arbitrary homeopathic dilution scale. GUNA's stated rationale is that it corresponds to the actual physiological concentration of these molecules in plasma and tissue, which happens to sit close to low-medium homeopathic dilutions — a range GUNA refers to as "low doses" specifically to distinguish the concept from classical homeopathic potency.

Why a Small Fraction of Receptors Is Enough

The low-dose mechanism depends on a second concept: receptor redundancy. A typical cell may carry around 1,000 receptors for a given messenger, but GUNA's position — drawn from receptor pharmacology — is that only a small fraction of those receptors needs to be occupied to produce a large physiological response:

Sensitization of 10% of the membrane receptors specific for a hormone, interleukin or neuropeptide is able to activate 50% of the cellular function.

The combination of affinity (how well the ligand binds available receptors) and redundancy (how few receptors need occupying to produce a meaningful response) is, in GUNA's account, what makes a therapeutic effect achievable at minimal ligand concentration.

One important caveat GUNA is explicit about: because cytokines, hormones and neuropeptides are biological molecules acting through this receptor mechanism, they do not follow the classical homeopathic "inversion of effect" principle across dilutions. Their biological efficacy is tied to physiological concentration, not to potency in the classical homeopathic sense. To dampen a pro-inflammatory cytokine such as IL-1, TNF-α or IL-6, GUNA's approach is to use a physiological concentration (typically 4CH) of an antagonist cytokine with Th2/Th3 polarity — IL-10 or TGF-β, for example, or an Anti-IL-1 preparation — rather than simply using a higher dilution of the same molecule.

Balancing Th1 and Th2

This antagonist logic extends into how GUNA thinks about the Th1/Th2 axis more broadly. In acute inflammatory (phlogistic) pathologies, the Th1 side of the balance is judged to be heavier, so therapy is weighted toward the Th2 cytokines — IL-4, IL-10, TGF-β — to redress it. In allergic pathologies, the Th2 side is heavier, so therapy is weighted toward Th1 — IL-12, IFN-γ.

The underlying principle GUNA states is that different cytokines can have different, even antagonistic, effects on the same target cell — IL-4 and IFN-γ, for instance, act on the same cells with opposing effects. Rather than adjusting the dilution of a single cytokine, GUNA's therapeutic strategy is to use antagonistic cytokines against one another to brake a given biological effect. In practice, this means the strategy overlaps conventional replacement therapy (hormone or immune) with homeopathic bioregulatory therapy: by providing a broader receptor supply through mixed regulatory-balance, low-dose molecules, conventional medication doses can sometimes be modulated or reduced, lowering the risk of collateral effects.

GUNA frames the whole model, at this point, as "an integrated and multifactorial strategy" — treating the human body as a holistic, complex system of interdependent sub-systems, where an intervention in one system (nervous, endocrine, or immune) inevitably has knock-on effects in the others. That framing is what leads directly into the three-phase clinical model — PNEI Rebalance, Drainage, and Symptom Treatment — covered in the next article in this series.

---

Featured products

Explore the full Guna range — GUNA Method, Cytokines and other GUNA-Method products.

Not sure which remedy is right for you?
Try our Natural Remedy Finder, or contact our team for guidance.

Related reading

• The GUNA Method Therapeutic Triangle: PNEI Rebalance, Drainage and Symptom Treatment
• Cytokines: How the Immune System's Messengers Work

Source: GUNA, *Physiological Regulating Medicine — GUNA Method* theory booklet.

Tags: Deep Guna Research, Guna Articles, GUNA Method